Tomoharu Sugie

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

Torsten O. Nielsen, Samuel Leung, David L. Rimm et al. · JNCI Journal of the National Cancer Institute · 2020 · 733 citations · Full text

Medicine, Oncology, Pathology +17

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Immunosuppression by CD4 ⁺ regulatory T cells induced by chronic retroviral infection

Michihiro Iwashiro, Ronald J. Messer, Karin E. Peterson et al. · Proceedings of the National Academy of Sciences · 2001 · 186 citations

Life Sciences, Cell Biology, Immunology +17

Expression and function of PD‐1 in human γδ T cells that recognize phosphoantigens

Masashi Iwasaki, Yoshimasa Tanaka, Hirohito Kobayashi et al. · European Journal of Immunology · 2010 · 157 citations

Life Sciences, Cell Biology, Immunology +17

Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer

Tomoharu Sugie, Terumasa Sawada, Nobumi Tagaya et al. · Annals of Surgical Oncology · 2013 · 156 citations

Medicine, Oncology, Breast Oncology +16